InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate® MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it was approved in 2004 as a non-invasive, outpatient, therapy for uterine fibroids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56632-insightec-fda-approves-exablate
Based on its recent analysis of the medical imaging market, Frost & Sullivan recognizes Siemens Healthcare with the 2011 North American Frost & Sullivan Award for New Product Innovation. Siemens Healthcare’s innovative Biograph mMR is the first scanner capable of simultaneously acquiring whole-body positron emission tomography (PET) and magnetic resonance imaging (MRI) data.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/frostsullivan/51015/
John Peden was one of those larger-than-life personalities. “When he would walk into a room, it was like all the attention was on him,” said his stepdaughter, Jenna Peden. “He just had this power emanating out of him.”
The 6-foot, 4-inch former U.S. Air Force captain was a respected dental surgeon in Nashville. He was active in his church and made many mission trips to provide dental care in Central America through Health Talents International.
That’s why it was such a shock to his family and friends when an MRI revealed a brain tumor the size of a golf ball. “Life as we knew it was no more,” said his wife, Vicki Peden. “John never worked another day in his life.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7100754-northwestern-mutual-client-stories-planning-preparation-pay-off/
